Cover Image
市場調查報告書

Laboratorios SALVAT S.A. 的產品平台分析

Laboratorios SALVAT S.A. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256081
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Laboratorios SALVAT S.A. 的產品平台分析 Laboratorios SALVAT S.A. - Product Pipeline Review - 2015
出版日期: 2015年09月30日 內容資訊: 英文 25 Pages
簡介

Laboratorios SALVAT S.A. 是總公司設立於西班牙的製藥企業,在40個以上的國家銷售個人醫療保健,代謝性疾病,泌尿系統,眼科,皮膚科,瘧疾等六大領域產品。

本報告提供Laboratorios SALVAT S.A. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Laboratorios SALVAT S.A. 的基本資料

  • Laboratorios SALVAT S.A. 概要
  • 主要資訊
  • 企業資料

Laboratorios SALVAT S.A. :R&D概要

  • 主要的治療範圍

Laboratorios SALVAT S.A. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Laboratorios SALVAT S.A. :開發中產品概況

  • 後期階段產品開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Laboratorios SALVAT S.A. :藥物簡介

  • (fluocinolone acetonide + ciprofloxacin hydrochloride)
  • G-238
  • tarafenacin
  • Stem Cell Therapy for Bone Regeneration

Laboratorios SALVAT S.A. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Laboratorios SALVAT S.A. :最新的開發平台資訊

Laboratorios SALVAT S.A. :開發暫停中的計劃

Laboratorios SALVAT S.A. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07625CDB

Summary

Global Markets Direct's, 'Laboratorios SALVAT S.A. - Product Pipeline Review - 2015', provides an overview of the Laboratorios SALVAT S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios SALVAT S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laboratorios SALVAT S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laboratorios SALVAT S.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laboratorios SALVAT S.A.'s pipeline products

Reasons to buy

  • Evaluate Laboratorios SALVAT S.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laboratorios SALVAT S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laboratorios SALVAT S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laboratorios SALVAT S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios SALVAT S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laboratorios SALVAT S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laboratorios SALVAT S.A. Snapshot
    • Laboratorios SALVAT S.A. Overview
    • Key Information
    • Key Facts
  • Laboratorios SALVAT S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Laboratorios SALVAT S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Laboratorios SALVAT S.A. - Pipeline Products Glance
    • Laboratorios SALVAT S.A. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Laboratorios SALVAT S.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
  • Laboratorios SALVAT S.A. - Drug Profiles
    • (fluocinolone acetonide + ciprofloxacin hydrochloride)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • G-238
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HCSVT-1001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • tarafenacin
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laboratorios SALVAT S.A. - Pipeline Analysis
    • Laboratorios SALVAT S.A. - Pipeline Products by Target
    • Laboratorios SALVAT S.A. - Pipeline Products by Route of Administration
    • Laboratorios SALVAT S.A. - Pipeline Products by Molecule Type
    • Laboratorios SALVAT S.A. - Pipeline Products by Mechanism of Action
  • Laboratorios SALVAT S.A. - Recent Pipeline Updates
  • Laboratorios SALVAT S.A. - Dormant Projects
  • Laboratorios SALVAT S.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laboratorios SALVAT S.A., Key Information
  • Laboratorios SALVAT S.A., Key Facts
  • Laboratorios SALVAT S.A. - Pipeline by Indication, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios SALVAT S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios SALVAT S.A. - Combination Treatment Modalities in Pipeline, 2015
  • Laboratorios SALVAT S.A. - Phase III, 2015
  • Laboratorios SALVAT S.A. - Phase II, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Target, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Route of Administration, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Molecule Type, 2015
  • Laboratorios SALVAT S.A. - Pipeline Products by Mechanism of Action, 2015
  • Laboratorios SALVAT S.A. - Recent Pipeline Updates, 2015
  • Laboratorios SALVAT S.A. - Dormant Developmental Projects,2015
  • Laboratorios SALVAT S.A., Subsidiaries

List of Figures

  • Laboratorios SALVAT S.A. - Pipeline by Top 10 Indication, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios SALVAT S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Top 10 Target, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Top 10 Route of Administration, 2015
  • Laboratorios SALVAT S.A. - Pipeline by Top 10 Molecule Type, 2015
  • Laboratorios SALVAT S.A. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top